HHC
CBPO

Hutchin Hill Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Hutchin Hill Capital’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$473K Buy
6,000
+3,500
+140% +$291K 0.13% 176
2017
Q3 		$231K Sell
2,500
-400
-14% -$38.4K 0.01% 673
2017
Q2 		$328K Buy
2,900
+500
+21% +$55.9K 0.01% 738
2017
Q1 		$240K Buy
+2,400
New +$256K 0.01% 831

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Hutchin Hill Capital's CBPO Position: Q4 2017 in Review

Hutchin Hill Capital increased its China Biologic Products Holdings, Inc. (CBPO) stake by 140% in Q4 2017, buying an estimated $291K and bringing the position to 6,000 shares worth $473K. The position accounts for 0.13% of the portfolio, ranked #176.

Hutchin Hill Capital first reported a position in CBPO in Q1 2017 and has held it in 4 quarters since. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • Hutchin Hill Capital held 6,000 shares of China Biologic Products Holdings, Inc. worth $473K as of Q4 2017.
  • Hutchin Hill Capital bought 3,500 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $291K.
  • China Biologic Products Holdings, Inc. made up 0.13% of Hutchin Hill Capital's portfolio in Q4 2017, its #176 holding.
  • Hutchin Hill Capital first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and has held it in 4 quarters since.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.